China SXT Pharmaceuticals Inc SXTCの前四半期の収益はどうでしたか?
China SXT Pharmaceuticals Incの収益見積もりはいくらですか?
China SXT Pharmaceuticals Incの収益品質スコアはどれくらいですか?
China SXT Pharmaceuticals Incはいつ収益を報告しますか?
China SXT Pharmaceuticals Incの予想収益はいくらですか?
China SXT Pharmaceuticals Incは収益予想を上回りましたか?
主要データ
前終値
$2.49
始値
$2.54
当日レンジ
$2.41 - $2.73
52週レンジ
$2.33 - $1,047
取引高
113.9K
平均取引高
266.0K
1株当たり利益(TTM)
-3.11
配当利回り
--
時価総額
$303.9M
SXTCとは何ですか?
China Sxt Pharmaceuticals, Inc. operates as a holding company, which engages in the research, development, manufacture, marketing, and sales of traditional Chinese medicine pieces (TCMP). The company is headquartered in Taizhou, Jiangsu and currently employs 75 full-time employees. The company went IPO on 2019-01-04. The firm sells different types of TCMP products, including Advanced TCMP and Regular TCMP. Advanced TCMP comprises of Directly-Oral-TCMP and After-Soaking-Oral TCMP. Regular TCMP is mainly for hospitals and drug stores for the treatment of various diseases or serving as dietary supplements. The firm sells its products under the brand Suxuantang.